Skip to main content

Research Repository

Advanced Search

New applications of heparin and other glycosaminoglycans

Andrade De Lima, M; Rudd, T; Yates, E

New applications of heparin and other glycosaminoglycans Thumbnail


T Rudd

E Yates


Heparin, the widely used pharmaceutical anticoagulant, has been in clinical use for well over half a century. Its introduction reduced clotting risks substantially and subsequent developments, including the introduction of low-molecular-weight heparin, made possible many major surgical interventions that today make heparin an indispensable drug. There has been a recent burgeoning of interest in heparin and related glycosaminoglycan (GAG) polysaccharides, such as chondroitin sulfates, heparan sulfate, and hyaluronate, as potential agents in various applications. This ability arises mainly from the ability of GAGs to interact with, and alter the activity of, a wide range of proteins. Here, we review new developments (since 2010) in the application of heparin and related GAGs across diverse fields ranging from thrombosis and neurodegenerative disorders to microbiology and biotechnology.


Andrade De Lima, M., Rudd, T., & Yates, E. (2017). New applications of heparin and other glycosaminoglycans. Molecules, 22, 749--749.

Journal Article Type Article
Acceptance Date Apr 28, 2017
Publication Date May 6, 2017
Journal Molecules
Publisher MDPI
Volume 22
Pages 749--749
Keywords heparin, glycosaminoglycans, chondroitin sulfate
Publisher URL


You might also like

Downloadable Citations